Long-Term Safety and Efficacy of Spark-Sponsored Gene Therapies in Males With Hemophilia A
Long-Term Safety and Efficacy of Spark-Sponsored Gene Therapies in Males With Hemophilia A
Active, not recruiting · NCT03432520 · Registry updated 2024-11-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Long-Term Safety and Efficacy of Spark-Sponsored Gene Therapies in Males With Hemophilia A | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, blood coagulation disease, coagulation protein disease, hematologic disorder, hemophilia A, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder | Active, not recruiting | Not stated | 2024-11-29 | NCT03432520 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Spark Therapeutics, Inc. | 4 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Boston Children's Hospital | Boston | United States | 343 |
| Hemophilia Center of Western Pennsylvania | Pittsburgh | United States | 7 |
| Mississippi Center for Advanced Medicine | Madison | United States | 7 |
| Oregon Health & Science University | Portland | United States | 261 |
| Pennsylvania State University Milton S. Hershey Medical Center | Hershey | United States | 1 |
| Royal Prince Alfred Hospital Department of Cell & Molecular Therapies | Sydney | Australia | 1 |
| St. Michael's Hospital | Toronto | Canada | 62 |
| The Alfred Hospital & Monash Medical Centre | Melbourne | Australia | 1 |
| The Children's Hospital of Philadelphia | Philadelphia | United States | 62 |
| Thomas Jefferson University | Philadelphia | United States | 165 |
| Truman Medical Centers | Kansas City | United States | 18 |
| Virginia Commonwealth University | Richmond | United States | 156 |